Skip to main content
Erschienen in: Angiogenesis 4/2022

26.07.2022 | Editorial

The rising impact of angiogenesis research

verfasst von: Arjan W. Griffioen, Andrew C. Dudley

Erschienen in: Angiogenesis | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

While inhibiting pathological angiogenesis has been long associated with the field of oncology, recent advances in angiogenesis research have impacted the progress of disease treatment for additional non-malignant diseases or chronic conditions in the fields of ophthalmology, cardiology, and gynecology. Moreover, stimulators of angiogenesis find application in ischemic diseases, while inhibitors of angiogenesis are being used to limit blood vessel formation, but in judicious ways that modify or “reprogram” the vasculature as a reinforcement for immunotherapy. We have noticed an increasing impact, as evidenced by increases in the total number of citations, in the literature surrounding the angiogenesis field suggesting that targeting angiogenesis per se is well established as a tractable approach for therapy in diverse conditions.
Literatur
1.
Zurück zum Zitat Griffioen AW, Dudley AC (2021) Angiogenesis: a year in review. Angiogenesis 24(2):195–196CrossRef Griffioen AW, Dudley AC (2021) Angiogenesis: a year in review. Angiogenesis 24(2):195–196CrossRef
2.
Zurück zum Zitat Margadant C (2021) Endothelial heterogeneity and plasticity. Angiogenesis 24(2):197–198CrossRef Margadant C (2021) Endothelial heterogeneity and plasticity. Angiogenesis 24(2):197–198CrossRef
3.
Zurück zum Zitat Koch PS, Lee KH, Goerdt S, Augustin HG (2021) Angiodiversity and organotypic functions of sinusoidal endothelial cells. Angiogenesis 24(2):289–310CrossRef Koch PS, Lee KH, Goerdt S, Augustin HG (2021) Angiodiversity and organotypic functions of sinusoidal endothelial cells. Angiogenesis 24(2):289–310CrossRef
4.
Zurück zum Zitat Pasut A, Becker LM, Cuypers A, Carmeliet P (2021) Endothelial cell plasticity at the single-cell level. Angiogenesis 24(2):311–326CrossRef Pasut A, Becker LM, Cuypers A, Carmeliet P (2021) Endothelial cell plasticity at the single-cell level. Angiogenesis 24(2):311–326CrossRef
5.
Zurück zum Zitat Jafree DJ, Long DA, Scambler PJ, Ruhrberg C (2021) Mechanisms and cell lineages in lymphatic vascular development. Angiogenesis 24(2):271–288CrossRef Jafree DJ, Long DA, Scambler PJ, Ruhrberg C (2021) Mechanisms and cell lineages in lymphatic vascular development. Angiogenesis 24(2):271–288CrossRef
6.
Zurück zum Zitat Mauri C, van Impel A, Mackay EW, Schulte-Merker S (2021) The adaptor protein Grb2b is an essential modulator for lympho-venous sprout formation in the zebrafish trunk. Angiogenesis 24(2):345–362CrossRef Mauri C, van Impel A, Mackay EW, Schulte-Merker S (2021) The adaptor protein Grb2b is an essential modulator for lympho-venous sprout formation in the zebrafish trunk. Angiogenesis 24(2):345–362CrossRef
7.
Zurück zum Zitat Ruter DL, Liu Z, Ngo KM et al (2021) SMAD6 transduces endothelial cell flow responses required for blood vessel homeostasis. Angiogenesis 24(2):387–398CrossRef Ruter DL, Liu Z, Ngo KM et al (2021) SMAD6 transduces endothelial cell flow responses required for blood vessel homeostasis. Angiogenesis 24(2):387–398CrossRef
8.
Zurück zum Zitat Canu G, Ruhrberg C (2021) First blood: the endothelial origins of hematopoietic progenitors. Angiogenesis 24(2):199–211CrossRef Canu G, Ruhrberg C (2021) First blood: the endothelial origins of hematopoietic progenitors. Angiogenesis 24(2):199–211CrossRef
9.
Zurück zum Zitat Hong X, Oh N, Wang K et al (2021) Human endothelial colony-forming cells provide trophic support for pluripotent stem cell-derived cardiomyocytes via distinctively high expression of neuregulin-1. Angiogenesis 24(2):327–344CrossRef Hong X, Oh N, Wang K et al (2021) Human endothelial colony-forming cells provide trophic support for pluripotent stem cell-derived cardiomyocytes via distinctively high expression of neuregulin-1. Angiogenesis 24(2):327–344CrossRef
10.
Zurück zum Zitat Tang X, Wang JJ, Wang J, Abboud HE, Chen Y, Zhang SX (2021) Endothelium-specific deletion of Nox4 delays retinal vascular development and mitigates pathological angiogenesis. Angiogenesis 24(2):363–377CrossRef Tang X, Wang JJ, Wang J, Abboud HE, Chen Y, Zhang SX (2021) Endothelium-specific deletion of Nox4 delays retinal vascular development and mitigates pathological angiogenesis. Angiogenesis 24(2):363–377CrossRef
11.
Zurück zum Zitat Smadja DM, Mentzer SJ, Fontenay M et al (2021) COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis 24(4):755–788CrossRef Smadja DM, Mentzer SJ, Fontenay M et al (2021) COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis 24(4):755–788CrossRef
12.
Zurück zum Zitat Ackermann M, Mentzer SJ, Jonigk D (2020) Pulmonary Vascular Pathology in Covid-19 Reply. N Engl J Med 383(9):888–889PubMed Ackermann M, Mentzer SJ, Jonigk D (2020) Pulmonary Vascular Pathology in Covid-19 Reply. N Engl J Med 383(9):888–889PubMed
13.
Zurück zum Zitat Smadja DM, Guerin CL, Chocron R et al (2020) Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis 23(4):611–620CrossRef Smadja DM, Guerin CL, Chocron R et al (2020) Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis 23(4):611–620CrossRef
14.
Zurück zum Zitat Henry BM, de Oliveira MHS, Cheruiyot I et al (2021) Circulating level of Angiopoietin-2 is associated with acute kidney injury in coronavirus disease 2019 (COVID-19). Angiogenesis 24(3):403–406CrossRef Henry BM, de Oliveira MHS, Cheruiyot I et al (2021) Circulating level of Angiopoietin-2 is associated with acute kidney injury in coronavirus disease 2019 (COVID-19). Angiogenesis 24(3):403–406CrossRef
15.
Zurück zum Zitat Philippe A, Chocron R, Gendron N et al (2021) Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis 24(3):505–517CrossRef Philippe A, Chocron R, Gendron N et al (2021) Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis 24(3):505–517CrossRef
16.
Zurück zum Zitat Philippe A, Gendron N, Bory O et al (2021) Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance. Angiogenesis 24(3):407–411CrossRef Philippe A, Gendron N, Bory O et al (2021) Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance. Angiogenesis 24(3):407–411CrossRef
17.
Zurück zum Zitat Bhogal P, Paul G, Collins G, Jaffer O (2021) Letter in response to: circulating von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis 24(3):413–415CrossRef Bhogal P, Paul G, Collins G, Jaffer O (2021) Letter in response to: circulating von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis 24(3):413–415CrossRef
18.
Zurück zum Zitat Rovas A, Osiaevi I, Buscher K et al (2021) Microvascular dysfunction in COVID-19: the MYSTIC study. Angiogenesis 24(1):145–157CrossRef Rovas A, Osiaevi I, Buscher K et al (2021) Microvascular dysfunction in COVID-19: the MYSTIC study. Angiogenesis 24(1):145–157CrossRef
19.
Zurück zum Zitat Unterleuthner D, Neuhold P, Schwarz K et al (2020) Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer. Angiogenesis 23(2):159–177CrossRef Unterleuthner D, Neuhold P, Schwarz K et al (2020) Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer. Angiogenesis 23(2):159–177CrossRef
20.
Zurück zum Zitat Cao J, Liu X, Yang Y et al (2020) Decylubiquinone suppresses breast cancer growth and metastasis by inhibiting angiogenesis via the ROS/p53/ BAI1 signaling pathway. Angiogenesis 23(3):325–338CrossRef Cao J, Liu X, Yang Y et al (2020) Decylubiquinone suppresses breast cancer growth and metastasis by inhibiting angiogenesis via the ROS/p53/ BAI1 signaling pathway. Angiogenesis 23(3):325–338CrossRef
21.
Zurück zum Zitat Detter MR, Shenkar R, Benavides CR et al (2020) Novel murine models of cerebral cavernous malformations. Angiogenesis 23(4):651–666CrossRef Detter MR, Shenkar R, Benavides CR et al (2020) Novel murine models of cerebral cavernous malformations. Angiogenesis 23(4):651–666CrossRef
22.
Zurück zum Zitat Radmanesh F, SadeghiAbandansari H, Ghanian MH et al (2021) Hydrogel-mediated delivery of microRNA-92a inhibitor polyplex nanoparticles induces localized angiogenesis. Angiogenesis 24(3):657–676CrossRef Radmanesh F, SadeghiAbandansari H, Ghanian MH et al (2021) Hydrogel-mediated delivery of microRNA-92a inhibitor polyplex nanoparticles induces localized angiogenesis. Angiogenesis 24(3):657–676CrossRef
23.
Zurück zum Zitat Wang J, Toan S, Zhou H (2020) New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury. Angiogenesis 23(3):299–314CrossRef Wang J, Toan S, Zhou H (2020) New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury. Angiogenesis 23(3):299–314CrossRef
24.
Zurück zum Zitat Blanchard L, Girard JP (2021) High endothelial venules (HEVs) in immunity, inflammation and cancer. Angiogenesis 24(4):719–753CrossRef Blanchard L, Girard JP (2021) High endothelial venules (HEVs) in immunity, inflammation and cancer. Angiogenesis 24(4):719–753CrossRef
25.
Zurück zum Zitat Fernandez-Chacon M, Garcia-Gonzalez I, Muhleder S, Benedito R (2021) Role of notch in endothelial biology. Angiogenesis 24(2):237–250CrossRef Fernandez-Chacon M, Garcia-Gonzalez I, Muhleder S, Benedito R (2021) Role of notch in endothelial biology. Angiogenesis 24(2):237–250CrossRef
26.
Zurück zum Zitat Marziano C, Genet G, Hirschi KK (2021) Vascular endothelial cell specification in health and disease. Angiogenesis 24(2):213–236CrossRef Marziano C, Genet G, Hirschi KK (2021) Vascular endothelial cell specification in health and disease. Angiogenesis 24(2):213–236CrossRef
27.
Zurück zum Zitat Greenspan LJ, Weinstein BM (2021) To be or not to be: endothelial cell plasticity in development, repair, and disease. Angiogenesis 24(2):251–269CrossRef Greenspan LJ, Weinstein BM (2021) To be or not to be: endothelial cell plasticity in development, repair, and disease. Angiogenesis 24(2):251–269CrossRef
Metadaten
Titel
The rising impact of angiogenesis research
verfasst von
Arjan W. Griffioen
Andrew C. Dudley
Publikationsdatum
26.07.2022
Verlag
Springer Netherlands
Erschienen in
Angiogenesis / Ausgabe 4/2022
Print ISSN: 0969-6970
Elektronische ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-022-09849-2

Weitere Artikel der Ausgabe 4/2022

Angiogenesis 4/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

TAVI bei kleinem Aortenklappenanulus: Es gibt noch ungeklärte Fragen

13.06.2024 TAVI Nachrichten

Zwischen selbstexpandierenden und ballonexpandierbaren TAVI-Klappen scheinen bezüglich der Klappenfunktion bei Aortenstenose und kleinem Aortenklappenanulus Unterschiede zu bestehen. Aber sind die überhaupt von klinischer Relevanz? Eine neue Studie liefert dazu Informationen.

Degenerierte Bioklappe: Ist Reoperation oder TAVI hier die bessere Option?

13.06.2024 TAVI Nachrichten

Im Fall eines Bioprothesen-Versagens nach Aortenklappenersatz kann ein notwendiger Revisionseingriff heute operativ oder kathetergestützt als Valve-in-Valve-TAVI vorgenommen werden. Eine Beobachtungsstudie lieferte neue Daten zum Vergleich beider Optionen.

Fortgeschrittenes Ovarial-Ca.: Unverdächtige Lymphknoten entfernen?

13.06.2024 ASCO 2024 Kongressbericht

Beim fortgeschrittenen Ovarialkarzinom und klinisch verdächtigen Lymphknoten in der Debulking-Op. ist die abdominale retroperitoneale Lymphadenektomie (RPL) Standard. Ohne verdächtige Lymphknoten ist der Nutzen fraglich.

Krillöl hilft nicht gegen Kniearthrose

13.06.2024 Arthrosen Nachrichten

Mit Krillöl zur Nahrungsergänzung lassen sich Schmerzen und Entzündungen bei Kniearthrose nicht stärker lindern als unter Placebo. Das hat eine kontrollierte Studie mit über 260 Betroffenen ergeben.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.